Soren Acquisition, a blank check company targeting the healthcare sector, raised $220 million by offering 22 million units at $10.00. Each unit consists of one share of common stock and one-third of one warrant, exercisable at $11.50.
The SPAC is led by CEO and Director Arghavan Di Rezze, who co-founded and held various roles at Theoria Medical, most recently as Chief Legal Officer. She is joined by CFO and Director Jamie Weber, the CFO of UNCAP Investment Management, and the Controller of SPARK Neuro. The SPAC plans to target businesses in the healthcare industry.
Soren Acquisition plans to list on the Nasdaq under the symbol SORNU. BTIG acted as sole bookrunner on the deal.
